PMID- 16144894 OWN - NLM STAT- MEDLINE DCOM- 20050915 LR - 20190619 IS - 1539-3704 (Electronic) IS - 0003-4819 (Linking) VI - 143 IP - 5 DP - 2005 Sep 6 TI - Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. PG - 355-61 AB - This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (http://www.guideline.gov). CN - U.S. Preventive Services Task Force LA - eng PT - Consensus Development Conference PT - Journal Article PT - Review PL - United States TA - Ann Intern Med JT - Annals of internal medicine JID - 0372351 SB - IM EIN - Ann Intern Med. 2005 Oct 4;143(7):547 CIN - Ann Intern Med. 2005 Sep 6;143(5):388-9. PMID: 16144898 CIN - Ann Intern Med. 2006 Feb 21;144(4):303-4; discussion 304. PMID: 16490919 CIN - ACP J Club. 2006 Mar-Apr;144(2):37. PMID: 16539352 MH - Breast Neoplasms/*genetics/prevention & control MH - Evidence-Based Medicine MH - Female MH - *Genes, BRCA1 MH - *Genes, BRCA2 MH - Genetic Counseling MH - *Genetic Predisposition to Disease MH - Humans MH - Medical History Taking MH - *Mutation MH - Ovarian Neoplasms/*genetics/prevention & control MH - Risk Assessment RF - 58 EDAT- 2005/09/08 09:00 MHDA- 2005/09/16 09:00 CRDT- 2005/09/08 09:00 PHST- 2005/09/08 09:00 [pubmed] PHST- 2005/09/16 09:00 [medline] PHST- 2005/09/08 09:00 [entrez] AID - 143/5/355 [pii] AID - 10.7326/0003-4819-143-5-200509060-00011 [doi] PST - ppublish SO - Ann Intern Med. 2005 Sep 6;143(5):355-61. doi: 10.7326/0003-4819-143-5-200509060-00011.